Publications by authors named "Z Asghar"
Endobronchial lipoma is an extremely rare benign tumor, accounting for 0.1%-0.5% of all lung tumors.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluates whether the Insall-Salvati and Caton-Deschamps ratios align with normal distribution patterns in healthy knees, using data from 434 CT-scanned knees.
- Results showed that while the Insall-Salvati ratio identified the 98th centile correctly for patella alta, it overdiagnosed patella baja, while the Caton-Deschamps index also revealed discrepancies in diagnosing patella baja at the 5th centile.
- Overall, the study found poor inter-rater reliability between the two ratios, as indicated by a kappa coefficient of 0.01.
Diffuse alveolar hemorrhage (DAH) is a form of hemoptysis caused by disruption of the alveolar-capillary basement membrane causing alveolar bleeding. Inhalation of cocaine and other sympathomimetic agents are described as one of many pathologic causes. We describe what is to the author's knowledge the first reported case of DAH caused by inhalation of bupropion, a norepinephrine-dopamine reuptake inhibitor, which was successfully treated with systemic steroids.
View Article and Find Full Text PDFAim: We aimed to achieve consensus among NHS and community stakeholders to identify and prioritise innovations in Community First Responder (CFR) schemes.
Methods: We conducted a mixed-methods study, adopting a modified nominal group technique with participants from ambulance services, CFR schemes and community stakeholders. The 1-day consensus workshop consisted of four sessions: introduction of innovations derived from primary research; round-robin discussions to generate new ideas; discussion and ranking of innovations; feedback of ranking, re-ranking and concluding statements.
Article Synopsis
- Despite advancements in coronary artery disease (CAD) management, major cardiovascular events continue, and the use of low-dose rivaroxaban (2.5 mg) in combination with aspirin is being analyzed for its effectiveness compared to aspirin alone.
- A meta-analysis of five randomized controlled trials with over 41,000 participants showed that low-dose rivaroxaban significantly lowers risks of all-cause mortality, myocardial infarction, and stroke, but increases the risk of major bleeding.
- The study concludes that while low-dose rivaroxaban offers survival benefits for CAD patients, careful consideration of bleeding risks is important, and further research is needed to evaluate its safety compared to other treatments like dual antiplatelet therapy